Foto del docente

Manuela Bartolini

Full Professor

Department of Pharmacy and Biotechnology

Academic discipline: CHEM-07/A Pharmaceutical Chemistry

Publications

De Simone, Angela*; Naldi, Marina; Bartolini, Manuela; Davani, Lara; Andrisano, Vincenza, Immobilized Enzyme Reactors: an Overview of Applications in Drug Discovery from 2008 to 2018, «CHROMATOGRAPHIA», 2019, 82, pp. 425 - 441 [Scientific article]

De Simone A.; Naldi M.; Tedesco D.; Milelli A.; Bartolini M.; Davani L.; Widera D.; Dallas M.L.; Andrisano V., Investigating in vitro amyloid peptide 1−42 aggregation: Impact of higher molecular weight stable adducts, «ACS OMEGA», 2019, 4, pp. 12308 - 12318 [Scientific article]Open Access

Tramarin, Anna; Tedesco, Daniele; Naldi, Marina; Baldassarre, Maurizio; Bertucci, Carlo; Bartolini, Manuela*, New insights into the altered binding capacity of pharmaceutical-grade human serum albumin: site-specific binding studies by induced circular dichroism spectroscopy, «JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS», 2019, 162, pp. 171 - 178 [Scientific article]

Chalupova K.; Korabecny J.; Bartolini M.; Monti B.; Lamba D.; Caliandro R.; Pesaresi A.; Brazzolotto X.; Gastellier A.-J.; Nachon F.; Pejchal J.; Jarosova M.; Hepnarova V.; Jun D.; Hrabinova M.; Dolezal R.; Zdarova Karasova J.; Mzik M.; Kristofikova Z.; Misik J.; Muckova L.; Jost P.; Soukup O.; Benkova M.; Setnicka V.; Habartova L.; Chvojkova M.; Kleteckova L.; Vales K.; Mezeiova E.; Uliassi E.; Valis M.; Nepovimova E.; Bolognesi M.L.; Kuca K., Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease, «EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY», 2019, 168, pp. 491 - 514 [Scientific article]Open Access

Ramos, E.; Palomino-Antolin, A.; Bartolini, M.; Iriepa, I.; Moraleda, I.; Diez-Iriepa, D.; Samadi, A.; Cortina, C. V.; Chioua, M.; Egea, J.; Romero, A.; Marco-Contelles, J., Quinoxalinetacrine QT78, a cholinesterase inhibitor as a potential ligand for Alzheimer’s disease therapy, «MOLECULES», 2019, 24, pp. 1503 - 1514 [Scientific article]Open Access

Fabini E.; Manoni E.; Ferroni C.; Del Rio A.; Bartolini M., Small-molecule inhibitors of lysine methyltransferases SMYD2 and SMYD3: Current trends, «FUTURE MEDICINAL CHEMISTRY», 2019, 11, pp. 901 - 921 [Scientific article]

Bertoni S., Tedesco D., Bartolini M., Passerini N., Albertini B., Solid lipid microparticles for oral delivery of catalase: focus on the protein integrity and gastric protection, in: 3rd European Conference on Pharmaceutics, 2019, pp. 1 - 2 (atti di: 3rd European Conference on Pharmaceutics, Bologna, 25-26 March 2019) [Contribution to conference proceedings]

AlFadly E.D.; Elzahhar P.A.; Tramarin A.; Elkazaz S.; Shaltout H.; Abu-Serie M.M.; Janockova J.; Soukup O.; Ghareeb D.A.; El-Yazbi A.F.; Rafeh R.W.; Bakkar N.-M.Z.; Kobeissy F.; Iriepa I.; Moraleda I.; Saudi M.N.S.; Bartolini M.; Belal A.S.F., Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: Multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase, «EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY», 2019, 167, pp. 161 - 186 [Scientific article]

Roldan-Pena J.M.; Romero-Real V.; Hicke J.; Maya I.; Franconetti A.; Lagunes I.; Padron J.M.; Petralla S.; Poeta E.; Naldi M.; Bartolini M.; Monti B.; Bolognesi M.; Lopez O.; Fernandez-Bolanos J.G., Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors, «EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY», 2019, 181, Article number: 111550 , pp. 111550 - 111565 [Scientific article]

Bartolini, Manuela*; Marco-Contelles, José, Tacrines as Therapeutic Agents for Alzheimer's Disease. IV. The Tacripyrines and Related Annulated Tacrines, «THE CHEMICAL RECORD», 2019, 19, pp. 927 - 937 [Scientific article]

Fabini E.; Talibov V.O.; Mihalic F.; Naldi M.; Bartolini M.; Bertucci C.; Del Rio A.; Danielson U.H., Unveiling the Biochemistry of the Epigenetic Regulator SMYD3, «BIOCHEMISTRY», 2019, 58, pp. 3634 - 3645 [Scientific article]

de simone a, naldi m, tedesco d, bartolini m, andrisano v, A multi-methodological approach for the investigation of β-Amyloid-CORMs interaction: an LC-ESI/MS and Circular Dichroism study., in: 10° MS pharma day book of abstracts, 2018, pp. 15 - 16 (atti di: 10° MS pharma day, Colleretto Giacosa (TO), 24-26 Ottobre) [Contribution to conference proceedings]

Andrisano, Vincenza*; Naldi, Marina; De Simone, Angela; Bartolini, Manuela, A patent review of butyrylcholinesterase inhibitors and reactivators 2010–2017, «EXPERT OPINION ON THERAPEUTIC PATENTS», 2018, 28, pp. 455 - 465 [Scientific article]

A De Simone; M Naldi; D Tedesco; M Bartolini; V Andrisano, β-Amyloid-CORMs interaction monitoring by LC-ESI/MS and Circular Dichroism studies, in: Med Chem Sicily 2018, 2018, pp. 18 - 18 (atti di: Med Chem Sicily 2018, Palermo, 17-20 July 2018) [Contribution to conference proceedings]

Fabini, Edoardo; Tramarin, Anna; Bartolini, Manuela*, Combination of human acetylcholinesterase and serum albumin sensing surfaces as highly informative analytical tool for inhibitor screening, «JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS», 2018, 155, pp. 177 - 184 [Scientific article]